{
  "meta": {
    "title": "25_Screening_Of_Disease",
    "url": "https://brainandscalpel.vercel.app/25-screening-of-disease-13176da6.html",
    "scrapedAt": "2025-11-30T06:59:01.397Z"
  },
  "questions": [
    {
      "id": 90202,
      "choices": [
        {
          "id": 220651,
          "text": "A and B"
        },
        {
          "id": 220652,
          "text": "A and C"
        },
        {
          "id": 220653,
          "text": "B and C"
        },
        {
          "id": 220654,
          "text": "C and D"
        }
      ],
      "text": "There are several points in the course of a disease process : a. Disease onset b. Point of first possible detection c. Final critical point d. Usual time of diagnosis e. Final outcome For a screening programme to be effective it should be applied between :",
      "unique_key": "Q2852457",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985733,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Between B and C) For a screening program to be effective, it should ideally be applied between the point of first possible detection (B) and the final critical point (C). This is because screening aims to identify the disease at a stage when intervention can alter its course and improve outcomes. The period between B and C is also known as the \"critical window\" or \"detectable preclinical phase\", where the disease can be detected early but before it has reached a stage where treatment becomes less effective or futile. Screening programs work best when they are applied in the window of opportunity where the disease is detectable but has not yet reached the critical point (C). During this phase: The disease is present but often asymptomatic. Early detection and treatment can significantly improve the prognosis and prevent adverse outcomes. Incorrect Options: A (Between A and B): Disease onset (A) represents the time when the disease begins at a cellular or molecular level. However, at this stage, the disease is usually undetectable by current screening methods. (B). Screening applied before the point of first possible detection (B) is ineffective because there are no diagnostic tools capable of identifying the disease before it can be detected B (Between A and C): Although this period includes the critical window (B to C), starting the screening too early (A to B) would waste resources, as the disease cannot be detected before B. Screening before B is impractical and adds no value to disease detection or management. D (Between C and D): The final critical point (C) marks the stage where the disease has progressed to a level where early intervention is no longer effective, and the prognosis is already determined. Screening at this stage offers little to no benefit because the disease may already be symptomatic or too advanced for intervention to make a significant difference.",
      "correct_choice_id": 220653,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30961981701694541/30961981701694541.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30961981701694541/30961981701694541.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90203,
      "choices": [
        {
          "id": 220655,
          "text": "Sensitivity"
        },
        {
          "id": 220656,
          "text": "Specificity"
        },
        {
          "id": 220657,
          "text": "Positive predictive value"
        },
        {
          "id": 220658,
          "text": "Negative predictive value"
        }
      ],
      "text": "The diagnostic power of a test to correctly exclude the disease is reflected by :",
      "unique_key": "Q4895988",
      "question_audio": null,
      "question_video": null,
      "map_id": 34735965,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (Negative Predictive Value). Negative Predictive Value (NPV) measures the diagnostic power of a test to correctly exclude the presence of a disease. It is defined as the proportion of individuals with a negative test result who truly do not have the disease. A high NPV means that the test is reliable in ruling out the disease when the result is negative. This is especially important in clinical settings where excluding a disease is critical to avoid unnecessary treatments or interventions. NPV depends not only on the test's intrinsic characteristics (sensitivity and specificity) but also on the prevalence of the disease in the population being tested. Lower disease prevalence generally increases NPV because there are fewer true cases of the disease. Reasons why other options are incorrect: Option A (Sensitivity): Sensitivity refers to a test's ability to correctly identify individuals who have the disease (true positives). While sensitivity is crucial for detecting the disease, it does not reflect the test's ability to exclude it. Therefore, this option is incorrect in the context of ruling out disease. Option B (Specificity): Specificity measures the test's ability to correctly identify individuals who do not have the disease (true negatives). While specificity is related to ruling out the disease, it does not directly indicate the probability that a negative result truly excludes the disease. Specificity is an intrinsic property of the test, while NPV takes into account both specificity and disease prevalence, making this option incorrect. Option C (Positive Predictive Value): Positive Predictive Value (PPV) measures the proportion of individuals with a positive test result who truly have the disease. PPV reflects the diagnostic power of the test to confirm the disease, not to exclude it. This makes it unrelated to the question's focus, so this option is incorrect.",
      "correct_choice_id": 220658,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29753301701694552/29753301701694552.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29753301701694552/29753301701694552.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90204,
      "choices": [
        {
          "id": 220659,
          "text": "Disease onset and first critical diagnosis"
        },
        {
          "id": 220660,
          "text": "Disease onset and first possible point of detection"
        },
        {
          "id": 220661,
          "text": "First possible point of detection and final critical point"
        },
        {
          "id": 220662,
          "text": "First possible point to detection and usual time of diagnosis"
        }
      ],
      "text": "Lead time refers to the time between",
      "unique_key": "Q2091853",
      "question_audio": null,
      "question_video": null,
      "map_id": 34509196,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (First possible point of detection and usual time of diagnosis). Lead time refers to the time gained by detecting a disease earlier through screening compared to the usual time of diagnosis when symptoms appear. It is the period between the first possible point of detection (B), when the disease can be identified using screening tools, and the usual time of diagnosis (D), which typically occurs after symptoms develop. A longer lead time allows for earlier treatment and potentially improves outcomes by intervening before the disease progresses to a more advanced stage. Thus, lead time is a critical concept in evaluating the effectiveness of a screening program. Incorrect Options: Option A (Disease onset and first critical diagnosis): This is incorrect because lead time does not refer to the period between disease onset (A) and the time of critical diagnosis. Disease onset can occur at a molecular or subclinical level that cannot yet be detected. Additionally, \"critical diagnosis\" is not relevant in defining lead time, as the focus is on the difference between screening detection and usual clinical diagnosis. Option B (Disease onset and first possible point of detection): This option is incorrect because the period between disease onset (A) and first possible point of detection (B) reflects the preclinical phase, not lead time. Screening programs cannot operate during this phase because the disease is undetectable at this stage, making this option unrelated to the concept of lead time. Option C (First possible point of detection and final critical point): This is incorrect because the time between the first possible detection (B) and the final critical point (C) represents the window for effective intervention, not lead time. While this interval is important for assessing the utility of screening, it does not involve the usual time of diagnosis, which is central to the definition of lead time.",
      "correct_choice_id": 220662,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57642211701694572/57642211701694572.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57642211701694572/57642211701694572.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90205,
      "choices": [
        {
          "id": 220663,
          "text": "Low case fatality rate"
        },
        {
          "id": 220664,
          "text": "Diagnostic tools not available"
        },
        {
          "id": 220665,
          "text": "No effective treatment available"
        },
        {
          "id": 220666,
          "text": "Early diagnosis can change disease course because of effective treatment"
        }
      ],
      "text": "Screening for condition recommended when :",
      "unique_key": "Q2676954",
      "question_audio": null,
      "question_video": null,
      "map_id": 34824850,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (Early diagnosis can change disease course because of effective treatment). Screening programs are recommended for conditions where detecting the disease early can significantly impact the patient's prognosis due to the availability of effective treatment. Early diagnosis, achieved through screening, allows for timely intervention, which can prevent disease progression, reduce complications, and improve survival rates. This principle aligns with the primary goal of screening: identifying diseases at a stage where intervention can alter the course of the disease for the better. Without effective treatment, early detection would not provide meaningful benefits, making screening unnecessary or even unethical in such cases. Reasons why other options are incorrect: Option A (Low case fatality rate): This is incorrect because screening is generally prioritized for conditions with a high case fatality rate, where early detection can reduce mortality. For conditions with a low case fatality rate, the urgency and need for screening are lower, as the disease may have minimal impact on overall health outcomes even without early detection. Option B (Diagnostic tools not available): This is incorrect because screening is dependent on the availability of reliable and valid diagnostic tools. If diagnostic tools are not available, screening would be ineffective or could lead to misdiagnosis and harm. The presence of accurate and accessible diagnostic tests is a prerequisite for a successful screening program. Option C (No effective treatment available): This is incorrect because screening is not recommended for conditions without effective treatment. Detecting a disease early is only beneficial if there is a treatment or intervention that can alter the disease's progression or improve quality of life. Screening for conditions with no effective treatment would not improve patient outcomes and could lead to unnecessary anxiety or interventions.",
      "correct_choice_id": 220666,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/137671701694582/137671701694582.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/137671701694582/137671701694582.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90206,
      "choices": [
        {
          "id": 220667,
          "text": "Testing for infection or disease in population in individuals who are not seeking health care"
        },
        {
          "id": 220668,
          "text": "It is defined presumptive identification of unrecognized disease"
        },
        {
          "id": 220669,
          "text": "Search for unrecognized disease or defect by means of rapidly applied test, examination or other procedures in apparently healthy individuals"
        },
        {
          "id": 220670,
          "text": "Use of clinical or laboratory tests to detect disease in individual seeking health care for other reasons"
        }
      ],
      "text": "Screening is done because of all except:",
      "unique_key": "Q3696804",
      "question_audio": null,
      "question_video": null,
      "map_id": 34969904,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (Use of clinical or laboratory tests to detect disease in individuals seeking health care for other reasons). Screening is fundamentally different from diagnostic testing. Screening is aimed at identifying unrecognized diseases or conditions in apparently healthy individuals who are not actively seeking healthcare for symptoms of the condition. It involves the use of simple, rapid tests or procedures to detect early signs of disease in asymptomatic individuals. On the other hand, using clinical or laboratory tests to detect disease in individuals seeking health care for other reasons is not considered screening but rather diagnostic or incidental testing. Screening focuses on population-level health interventions rather than individual diagnostic needs. Incorrect Options: Option A (Testing for infection or disease in population in individuals who are not seeking health care): This is correct because screening involves actively testing asymptomatic individuals in a population who are not seeking healthcare. This proactive approach helps in early detection of conditions, which can then be managed to prevent complications. Option B (It is defined as presumptive identification of unrecognized disease): This is correct because screening is a process aimed at the presumptive identification of unrecognized diseases or conditions. The focus is on early detection to allow for further confirmatory diagnostic tests and timely intervention. Option C (Search for unrecognized disease or defect by means of rapidly applied test, examination or other procedures in apparently healthy individuals): This is correct because screening specifically targets apparently healthy individuals. It employs tests that are simple, cost-effective, and easy to administer to detect unrecognized conditions. This is a defining characteristic of screening programs.",
      "correct_choice_id": 220670,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90207,
      "choices": [
        {
          "id": 220671,
          "text": "B, D, E, H"
        },
        {
          "id": 220672,
          "text": "A, C, E, H"
        },
        {
          "id": 220673,
          "text": "B, C, F, G"
        },
        {
          "id": 220674,
          "text": "A, D, E, G"
        }
      ],
      "text": "Which of the following are the characteristics features of screening tests? a. Done on healthy people b. Done on unhealthy people c. More accurate d. Less accurate e. Less expensive f. Moe expensive g. Not a basis for treatment h. Used as base for treatment Select the correct answer using the code given below",
      "unique_key": "Q1497781",
      "question_audio": null,
      "question_video": null,
      "map_id": 34595995,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (A, D, E, G). Screening tests are used to detect unrecognized diseases or conditions in apparently healthy individuals (A). Unlike diagnostic tests, they are designed to be less accurate (D) but serve as a preliminary step to identify individuals who may require further investigation. Screening tests are also less expensive (E) because they are typically administered on a larger scale to asymptomatic populations, making cost-efficiency a priority. Importantly, screening results are not a basis for treatment (G) but rather a tool to identify individuals who need diagnostic confirmation and subsequent management if necessary. Incorrect Options: Option A (B, D, E, H): B (Done on unhealthy people): Incorrect, as screening is specifically designed for healthy or asymptomatic individuals to detect potential diseases early. Tests for unhealthy people are diagnostic, not screening. H (Used as base for treatment): Incorrect, because screening tests are not definitive and cannot directly form the basis for treatment. They only identify individuals who may need further diagnostic evaluation. Option B (A, C, E, H): C (More accurate): Incorrect, as screening tests are less accurate than diagnostic tests. They prioritize sensitivity over specificity to ensure fewer cases are missed, even at the cost of false positives. H (Used as base for treatment): Incorrect for the same reason as above—screening results are not used directly for treatment but for guiding further investigation. Option C (B, C, F, G): B (Done on unhealthy people): Incorrect, as explained above—screening is intended for healthy individuals. C (More accurate): Incorrect, as screening tests are less accurate. F (More expensive): Incorrect, because screening is designed to be cost-effective for large populations. G (Not a basis for treatment): This part is correct, but the other choices in this option make it invalid.",
      "correct_choice_id": 220674,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8101951701694594/8101951701694594.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8101951701694594/8101951701694594.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90208,
      "choices": [
        {
          "id": 220675,
          "text": "Cervical pap smear in a 40 year old female"
        },
        {
          "id": 220676,
          "text": "Neonatal screening in a newborn for hypothyroidism"
        },
        {
          "id": 220677,
          "text": "Screening of immigrants in a country"
        },
        {
          "id": 220678,
          "text": "Urine for sugar screening in a 40 year old male"
        }
      ],
      "text": "Which of the following is an example of prospective screening :",
      "unique_key": "Q2390178",
      "question_audio": null,
      "question_video": null,
      "map_id": 34464029,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Screening of immigrants in a country). Prospective screening refers to screening conducted in a targeted population, often for specific conditions, as part of a program designed to identify diseases or conditions in advance and manage them proactively. Screening of immigrants entering a country is a classic example of prospective screening because it involves identifying health conditions (such as infectious diseases) in a defined population (immigrants) as part of a planned health assessment process. This is often done to ensure public health safety and provide appropriate interventions or treatments when necessary. Incorrect Options: Option A (Cervical pap smear in a 40-year-old female): This is incorrect because a cervical Pap smear is an example of opportunistic screening or routine screening. It is typically done during a health check-up in individuals seeking care, rather than as part of a structured program targeting a specific group. It does not involve a targeted population in advance, which is essential for prospective screening. Option B (Neonatal screening in a newborn for hypothyroidism): This is incorrect because neonatal screening for hypothyroidism is an example of universal screening, as it is routinely performed on all newborns in many healthcare systems to detect specific congenital conditions. While it is preventive, it is not considered prospective screening, as it targets all newborns rather than a specific subgroup or population. Option D (Urine for sugar screening in a 40-year-old male): This is incorrect because urine sugar screening is another example of opportunistic screening. It is performed during routine health check-ups when individuals present for care, rather than targeting a preselected or predefined population in advance.",
      "correct_choice_id": 220677,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36972551701694606/36972551701694606.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36972551701694606/36972551701694606.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90209,
      "choices": [
        {
          "id": 220679,
          "text": "Prostate cancer"
        },
        {
          "id": 220680,
          "text": "Lung cancer"
        },
        {
          "id": 220681,
          "text": "Colon cancer"
        },
        {
          "id": 220682,
          "text": "Ovarian cancer"
        }
      ],
      "text": "In which of the following disease screening procedure increase the overall survival maximum :",
      "unique_key": "Q5956429",
      "question_audio": null,
      "question_video": null,
      "map_id": 34422158,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Colon cancer). Screening procedures have been shown to significantly increase overall survival in colon cancer. This is primarily due to the slow progression of the disease, which allows for effective early detection of precancerous lesions (such as polyps) through screening tools like colonoscopy, sigmoidoscopy, and fecal occult blood testing (FOBT). Detecting and removing precancerous polyps prevents the development of invasive cancer, and early detection of colon cancer improves survival rates as it can often be treated successfully in its early stages. Screening for colon cancer is widely supported by evidence and is associated with reduced mortality and increased survival rates. Incorrect Options: Option A (Prostate cancer): Screening for prostate cancer, such as through prostate-specific antigen (PSA) testing, has been controversial. While PSA screening can detect prostate cancer early, it often identifies slow-growing cancers that may not progress or affect survival (overdiagnosis). Additionally, there is limited evidence that screening significantly reduces overall mortality, and it may lead to unnecessary interventions that carry risks. Thus, the overall survival benefit from prostate cancer screening is less compared to colon cancer. Option B (Lung cancer): Lung cancer screening using low-dose computed tomography (LDCT) has shown some benefit in reducing lung cancer mortality in high-risk populations (e.g., heavy smokers). However, lung cancer tends to progress more rapidly, limiting the window for early detection. Additionally, lung cancer screening is less effective at increasing overall survival compared to colon cancer screening due to higher rates of advanced disease at diagnosis and challenges in treatment. Option D (Ovarian cancer): Screening for ovarian cancer, such as through CA-125 testing or transvaginal ultrasound, has not been proven to significantly improve survival. Ovarian cancer often develops and spreads silently, and current screening methods are not sensitive or specific enough to detect it early in most cases. As a result, ovarian cancer screening does not have the same survival benefit as colon cancer screening.",
      "correct_choice_id": 220681,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7579701701694618/7579701701694618.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7579701701694618/7579701701694618.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90210,
      "choices": [
        {
          "id": 220683,
          "text": "History and clinical examination"
        },
        {
          "id": 220684,
          "text": "Colposcopy"
        },
        {
          "id": 220685,
          "text": "CT scan"
        },
        {
          "id": 220686,
          "text": "PAP smear"
        }
      ],
      "text": "Screening of cervical cancer at PHC level is done by :",
      "unique_key": "Q8737760",
      "question_audio": null,
      "question_video": null,
      "map_id": 34862585,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (History and clinical examination). At the Primary Health Centre (PHC) level, screening for cervical cancer is typically performed using basic, low-cost, and accessible methods such as history-taking and clinical examination. PHCs often serve rural or resource-limited areas where advanced tools may not be available. Visual Inspection with Acetic Acid (VIA) or Visual Inspection with Lugol’s Iodine (VILI) are commonly used at PHCs due to their simplicity, cost-effectiveness, and ability to identify high-risk individuals for referral. These methods are suitable for the PHC setting as they do not require specialized equipment or extensive training and allow for immediate triaging and follow-up. Incorrect Options: Option B (Colposcopy): This is incorrect because colposcopy is a specialized diagnostic tool that requires advanced equipment and trained personnel. It is not typically available at the PHC level, as it is more suitable for secondary or tertiary healthcare centers. Colposcopy is used to confirm abnormalities detected during screening, not as a primary screening tool at the PHC level. Option C (CT scan): This is incorrect because a CT scan is not used for screening cervical cancer. CT scans are imaging tools that help in staging or evaluating the extent of cancer once it has been diagnosed. They are expensive, require advanced infrastructure, and are unsuitable for primary-level screening. Option D (PAP smear): While Pap smears are an effective screening method for cervical cancer, they are not commonly performed at PHC levels in many resource-limited settings due to the need for laboratory infrastructure, trained cytologists, and equipment. Pap smears are more feasible at higher levels of healthcare where these resources are available.",
      "correct_choice_id": 220683,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68713101701694642/68713101701694642.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68713101701694642/68713101701694642.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90211,
      "choices": [
        {
          "id": 220687,
          "text": "Done on apparently healthy individuals"
        },
        {
          "id": 220688,
          "text": "It is less accurate"
        },
        {
          "id": 220689,
          "text": "Test result are not arbitrary and preliminary"
        },
        {
          "id": 220690,
          "text": "It can be used basis for treatment"
        }
      ],
      "text": "Screening test has the following features except:",
      "unique_key": "Q8182493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34551409,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (It can be used as basis for treatment). Screening tests are designed to identify individuals who may have a particular disease or condition before symptoms appear. They are typically performed on apparently healthy individuals (A) to detect potential health issues early. These tests are generally less accurate (B) than diagnostic tests, meaning they may produce false positives or false negatives. However, the results of screening tests are not arbitrary; they are based on established criteria and are used to identify individuals who may require further diagnostic evaluation. Importantly, the results of a screening test alone are not a basis for treatment (D). A positive screening result indicates the need for further diagnostic testing to confirm the presence of the disease before initiating treatment. Therefore, while screening tests are a crucial first step in disease detection, they do not directly lead to treatment decisions. Incorrect Options: A (Done on apparently healthy individuals): This is correct. Screening tests are specifically designed to be administered to individuals who do not exhibit symptoms of the disease, aiming to detect potential health issues early. B (It is less accurate): This is correct. Screening tests are generally less accurate than diagnostic tests, as they are designed to be simple, quick, and cost-effective, which may compromise their sensitivity and specificity. C (Test results are arbitrary and final): This is incorrect. Test results are not arbitrary; they are based on established criteria and are used to identify individuals who may require further diagnostic evaluation. While screening tests may have limitations, their results are not arbitrary.",
      "correct_choice_id": 220690,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45538651701694669/45538651701694669.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45538651701694669/45538651701694669.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90212,
      "choices": [
        {
          "id": 220691,
          "text": "True positive + false negatives"
        },
        {
          "id": 220692,
          "text": "False positives + True negatives"
        },
        {
          "id": 220693,
          "text": "True positives + False positive"
        },
        {
          "id": 220694,
          "text": "True positive + True negatives"
        }
      ],
      "text": "For the calculation of positive predictive value of a screening test the denominator is comprised of :",
      "unique_key": "Q9734517",
      "question_audio": null,
      "question_video": null,
      "map_id": 34758955,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (True positives + False positives). Positive Predictive Value (PPV) is a measure of the probability that subjects with a positive screening test result truly have the disease. It is calculated using the formula: PPV= True Positives/True Positives + False Positives This formula indicates that the denominator comprises all individuals who received a positive test result, including both those who truly have the disease (true positives) and those who do not (false positives). Therefore, the denominator is True Positives + False Positives. Reasons why other options are incorrect: Option A (True positive + False negatives): This is incorrect because the denominator for PPV should include all individuals who received a positive test result, not those who received a negative result. The combination of true positives and false negatives pertains to the calculation of sensitivity, not PPV. Option B (False positives + True negatives): This is incorrect because the denominator for PPV should include all individuals who received a positive test result. The combination of false positives and true negatives pertains to the calculation of specificity, not PPV. Option D (True positive + True negatives): This is incorrect because the denominator for PPV should include all individuals who received a positive test result. The combination of true positives and true negatives pertains to the calculation of accuracy, not PPV.",
      "correct_choice_id": 220693,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7467741701694695/7467741701694695.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7467741701694695/7467741701694695.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90213,
      "choices": [
        {
          "id": 220695,
          "text": "Sensitivity"
        },
        {
          "id": 220696,
          "text": "Specificity"
        },
        {
          "id": 220697,
          "text": "Yield"
        },
        {
          "id": 220698,
          "text": "Predictive accuracy"
        }
      ],
      "text": "All comprise inherent properties of a screening test except :",
      "unique_key": "Q6004071",
      "question_audio": null,
      "question_video": null,
      "map_id": 34119493,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Yield). Inherent properties of a screening test refer to characteristics that are intrinsic to the test itself and are not influenced by external factors such as disease prevalence in the population. These properties include: Sensitivity: The ability of the test to correctly identify individuals who have the disease (true positives). Specificity: The ability of the test to correctly identify individuals who do not have the disease (true negatives). Predictive Accuracy: The overall ability of the test to correctly classify individuals as diseased or non-diseased. Yield, on the other hand, refers to the proportion of individuals in a population who are identified as having the disease through screening. This measure is influenced by the prevalence of the disease in the population; higher prevalence leads to a higher yield. Therefore, yield is not an inherent property of the screening test itself but is affected by external factors. Incorrect Options: Option A (Sensitivity): This is correct. Sensitivity is an inherent property of a screening test, indicating its ability to correctly identify those with the disease. Option B (Specificity): This is correct. Specificity is an inherent property of a screening test, indicating its ability to correctly identify those without the disease. Option D (Predictive Accuracy): This is correct. Predictive accuracy is an inherent property of a screening test, reflecting its overall ability to correctly classify individuals as diseased or non-diseased.",
      "correct_choice_id": 220697,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54700311701694708/54700311701694708.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54700311701694708/54700311701694708.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90214,
      "choices": [
        {
          "id": 220699,
          "text": "Criterion validity"
        },
        {
          "id": 220700,
          "text": "Construct validity"
        },
        {
          "id": 220701,
          "text": "Discriminant validity"
        },
        {
          "id": 220702,
          "text": "Content validity"
        }
      ],
      "text": "The parameter of sensitivity and specificity are used for assessing :",
      "unique_key": "Q3092685",
      "question_audio": null,
      "question_video": null,
      "map_id": 34455040,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Criterion validity). Criterion validity refers to the extent to which a measure correlates with an outcome or criterion that is considered a gold standard. In the context of screening tests, sensitivity and specificity are fundamental parameters used to assess how well a test identifies the presence or absence of a disease compared to a gold standard. Sensitivity measures the proportion of actual positives correctly identified by the test, while specificity measures the proportion of actual negatives correctly identified. These metrics are essential for evaluating the diagnostic accuracy of a test, which is a key aspect of criterion validity. Incorrect Options: Option B (Construct validity): This is incorrect because construct validity pertains to whether a test measures the concept it intends to measure. While sensitivity and specificity are important for assessing criterion validity, they are not used to evaluate construct validity. Option C (Discriminant validity): This is incorrect because discriminant validity assesses whether concepts or measurements that are not supposed to be related are actually unrelated. Sensitivity and specificity do not directly measure discriminant validity. Option D (Content validity): This is incorrect because content validity examines whether a test covers the representative breadth of the concept it aims to measure. Sensitivity and specificity are not used to assess content validity.",
      "correct_choice_id": 220699,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90215,
      "choices": [
        {
          "id": 220703,
          "text": "0.90"
        },
        {
          "id": 220704,
          "text": "0.84"
        },
        {
          "id": 220705,
          "text": "0.16"
        },
        {
          "id": 220706,
          "text": "0.10"
        }
      ],
      "text": "A diagnostic test X has a sensitivity of 0.90 and a specificity of 0.50. The prevalence of disease Y in a certain population is 10%. What is the post-test probability (i.e., the probability that a person who tests positive actually has the disease)?",
      "unique_key": "Q8984069",
      "question_audio": null,
      "question_video": null,
      "map_id": 34020277,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (0.16). To calculate the post-test probability of disease after a positive test result, we use the formula: Post-test probability = (Sensitivity×Prevalence) / (Sensitivity×Prevalence) + ((1-Specificity)×(1-Prevalence)) Given: • Sensitivity = 0.90 ( • Specificity = 0.50 • Prevalence = 0.10 Applying the values: Post-test probability = (0.90 × 0.10) / (0.90 × 0.10) + ((1-0.50) × (1-0.10)) Post-test probability = 0.09 / 0.09 + (0.50×0.90) Post-test probability = 0.09 / 0.09 + 0.45 Post-test probability = 0.09 / 0.54 Post-test probability = 0.1667 Therefore, the post-test probability is approximately 0.16, or 16%. Incorrect Options: Option A (0.90): This is incorrect because a post-test probability of 0.90 would imply a 90% chance of having the disease after a positive test result, which is not supported by the given sensitivity, specificity, and prevalence. Option B (0.84): This is incorrect because a post-test probability of 0.84 would suggest an 84% chance of having the disease after a positive test result, which does not align with the calculated value of approximately 0.16. Option D (0.10): This is incorrect because a post-test probability of 0.10 would indicate a 10% chance of having the disease after a positive test result, which is lower than the calculated value of approximately 0.16.",
      "correct_choice_id": 220705,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90216,
      "choices": [
        {
          "id": 220707,
          "text": "Sensitivity is less than specificity"
        },
        {
          "id": 220708,
          "text": "Sensitivity is same as specificity"
        },
        {
          "id": 220709,
          "text": "PPV is more than NPV"
        },
        {
          "id": 220710,
          "text": "PPV is same as NPV"
        }
      ],
      "text": "True about the following is :<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/6206104Q.15.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9195616",
      "question_audio": null,
      "question_video": null,
      "map_id": 34638530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) PPV (Positive Predictive Value) is the same as NPV (Negative Predictive Value). Calculation of Sensitivity, Specificity, PPV, and NPV: From the table: • Positive ECG: MI present = 300, MI absent = 100 • Negative ECG: MI present = 25, MI absent = 75 • Sensitivity (True Positive Rate) = TP / (TP + FN) = 300 / (300 + 25) = 300 / 325 = 92.31% Specificity (True Negative Rate) = TN / (TN + FP) = 75 / (75 + 100) = 75 / 175 = 42.86% PPV (Positive Predictive Value) = TP / (TP + FP) = 300 / (300 + 100) = 300 / 400 = 75% NPV (Negative Predictive Value) = TN / (TN + FN) = 75 / (75 + 25) = 75 / 100 = 75% Here, the PPV is equal to the NPV at 75%. This is because the test's positive predictive value and negative predictive value are influenced by the proportion of true positives and true negatives, which are balanced in this scenario. Correct Answer: D (PPV is the same as NPV) PPV and NPV are both 75%, as calculated above, making them equal. Incorrect Options: A (Sensitivity is less than specificity): This is incorrect because the sensitivity (92.31%) is significantly higher than the specificity (42.86%). B (Sensitivity is the same as specificity): This is incorrect because sensitivity (92.31%) and specificity (42.86%) are not equal. Sensitivity is much higher. C (PPV is more than NPV): This is incorrect because PPV and NPV are both 75%, making them equal, not one higher than the other.",
      "correct_choice_id": 220710,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61998401701694740/61998401701694740.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61998401701694740/61998401701694740.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90217,
      "choices": [
        {
          "id": 220711,
          "text": "Prevalence"
        },
        {
          "id": 220712,
          "text": "Sensitivity"
        },
        {
          "id": 220713,
          "text": "Specificity"
        },
        {
          "id": 220714,
          "text": "Relative risk"
        }
      ],
      "text": "Positive predictive value is most affected by :",
      "unique_key": "Q4097979",
      "question_audio": null,
      "question_video": null,
      "map_id": 34642659,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Prevalence). Positive Predictive Value (PPV) refers to the probability that subjects with a positive test result truly have the disease. It is calculated using the formula: PPV = True Positives / True Positives + False Positives PPV is influenced by several factors, including: • Prevalence: The proportion of individuals in the population who actually have the disease. Higher prevalence increases the likelihood that a positive test result is a true positive. • Sensitivity: The ability of the test to correctly identify those with the disease. • Specificity: The ability of the test to correctly identify those without the disease. Among these, prevalence has the most significant impact on PPV. As prevalence increases, the proportion of true positives among all positive test results also increases, thereby raising the PPV. Conversely, in populations with low disease prevalence, even tests with high sensitivity and specificity may have a lower PPV due to the higher number of false positives. Reasons why other options are incorrect: Option B (Sensitivity): While sensitivity affects PPV, its impact is less pronounced than that of prevalence. High sensitivity reduces false negatives, but in low-prevalence settings, the effect on PPV is limited. Option C (Specificity): Specificity influences PPV by reducing false positives. However, in low-prevalence populations, even high specificity may not significantly increase PPV. Option D (Relative Risk): Relative risk is a measure used in epidemiological studies to compare the risk of an event between two groups. It does not directly affect PPV.",
      "correct_choice_id": 220711,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26627061701694823/26627061701694823.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26627061701694823/26627061701694823.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90218,
      "choices": [
        {
          "id": 220715,
          "text": "90%"
        },
        {
          "id": 220716,
          "text": "81%"
        },
        {
          "id": 220717,
          "text": "50%"
        },
        {
          "id": 220718,
          "text": "91%"
        }
      ],
      "text": "A diagnostic test for a particular disease has a sensitivity of 0.90 and a specificity 0.90. A single test is applied to each subject in the population in which the disease population is 10% . What is the probability that a person positive to this test, has disease :",
      "unique_key": "Q8478670",
      "question_audio": null,
      "question_video": null,
      "map_id": 34819927,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (50%). To determine the probability that a person who tests positive actually has the disease, we calculate the Positive Predictive Value (PPV). PPV is the proportion of positive test results that are true positives, indicating the actual presence of the disease. It is calculated using the formula: PPV = (Sensitivity × Prevalence) / (Sensitivity × Prevalence) + ((1-Specificity) × (1-Prevalence)) Given: • Sensitivity = 0.90 • Specificity = 0.90 • Prevalence = 10% (0.10) • Applying the values: PPV = (0.90 × 0.10) / (0.90 × 0.10) + ((1-0.90) × (1-0.10)) PPV = 0.09 / 0.09 + (0.10 × 0.90) PPV = 0.09 / 0.09 + 0.09 PPV = 0.09 / 0.18 PPV = 0.50 Therefore, the probability that a person who tests positive actually has the disease is 50%. Incorrect Options: Option A (90%): This is incorrect because a PPV of 90% would imply that 90% of positive test results are true positives, which is not supported by the given sensitivity, specificity, and prevalence. Option B (81%): This is incorrect because a PPV of 81% does not align with the calculated value of 50%. Option D (91%): This is incorrect because a PPV of 91% would suggest that 91% of positive test results are true positives, which is not consistent with the given data.",
      "correct_choice_id": 220717,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15927461701694908/15927461701694908.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15927461701694908/15927461701694908.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90219,
      "choices": [
        {
          "id": 220719,
          "text": "The sensitivity of temperature greater than 37.5 degree Celsius as a marker for appendicitis is 21/49"
        },
        {
          "id": 220720,
          "text": "The specificity of temperature greater than 37.5 degree Celsius as a marker for appendicitis is 42/70"
        },
        {
          "id": 220721,
          "text": "The positive predictive value of temperature greater than 37.5 degree Celsius as a marker for appendicitis is 21/30"
        },
        {
          "id": 220722,
          "text": "The Specificity of the test will depend upon the prevalence of appendicitis in the population is which it is applied"
        }
      ],
      "text": "In a group of patient’s presenting to a hospital emergency with abdominal pain, 30% of patients have acute appendicitis. 70% of patient with appendicitis. Have a temperature greater than 37.5 degree Celsius and 40% of patient without appendicitis have a temperature greater than 37.5 degree Celsius. Considering these findings , which of the following statement is correct :",
      "unique_key": "Q8594312",
      "question_audio": null,
      "question_video": null,
      "map_id": 34394889,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) • Prevalence of appendicitis = 30% → So in 100 patients, 30 have appendicitis, 70 do not • 70% of appendicitis patients have temperature > 37.5°C → 21 out of 30 patients with appendicitis have fever (True Positives) • 40% of patients without appendicitis have temperature > 37.5°C → 28 out of 70 patients without appendicitis have fever (False Positives) → The rest, 42 patients, have normal temp (True Negatives) Now evaluate each option: • Option A: The sensitivity of temperature >37.5°C as a marker for appendicitis is 21/49 Incorrect Sensitivity = True Positives / All with disease = 21 / 30 The denominator 49 is wrong—it should be 30. Correct sensitivity = 21/30 Option B: The specificity of temperature >37.5°C as a marker for appendicitis is 42/70 Specificity = True Negatives / All without disease = 42 / 70 Option C: The positive predictive value (PPV) of temperature >37.5°C as a marker for appendicitis is 21/30 Incorrect PPV = True Positives / All test positives Test positives = 21 (TP) + 28 (FP) = 49 So PPV = 21 / 49 Not 21 / 30 Option D: The specificity of the test will depend upon the prevalence of appendicitis in the population Incorrect Specificity is not affected by disease prevalence. It is an inherent property of the test in people without the disease.",
      "correct_choice_id": 220720,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90220,
      "choices": [
        {
          "id": 220723,
          "text": "True positives"
        },
        {
          "id": 220724,
          "text": "False positives"
        },
        {
          "id": 220725,
          "text": "False negatives"
        },
        {
          "id": 220726,
          "text": "True negatives"
        }
      ],
      "text": "Specificity of a screening test is the ability of a test to detect :",
      "unique_key": "Q1345288",
      "question_audio": null,
      "question_video": null,
      "map_id": 34216012,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) • Sensitivity/ Usefullness: Ability of the test to identify correctly those who have the disease/ TP • Specificity: Ability of the test to identify correctly those who don’t have the disease/ TN • PPV: If the test results are positive in this patient, what is the probability that this patient has the disease or in other words, what proportion/ percentage of patients who test positive actually have the disease in the question • NPV: If the test results are negative in this patient, what is the probability that this patient doesn’t have the disease",
      "correct_choice_id": 220726,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10911041701694953/10911041701694953.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10911041701694953/10911041701694953.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90221,
      "choices": [
        {
          "id": 220727,
          "text": "Net sensitivity and net specificity are both increased"
        },
        {
          "id": 220728,
          "text": "Net sensitivity is decreased and and net specificity is increased"
        },
        {
          "id": 220729,
          "text": "Net sensitivity is increased and net specificity is increased"
        },
        {
          "id": 220730,
          "text": "Net sensitivity remain the same and net specificity is increased"
        }
      ],
      "text": "If the hemoccult test is negative for screening of colonic cancer, no further test is done. If the hemoccult test is positive the individual will have a second stool sample tested with the hemoccult II test. If this second for blood. the individual will be referred for more extensive evaluation. The effect of net sensitivity and net specificity of this method of screening is:",
      "unique_key": "Q1698434",
      "question_audio": null,
      "question_video": null,
      "map_id": 34115539,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Net sensitivity is decreased and net specificity is increased). In the described screening process, individuals with a positive initial hemoccult test undergo a second hemoccult II test. This sequential testing approach affects the overall sensitivity and specificity as follows: Net Sensitivity: The overall sensitivity decreases because the second test introduces an additional opportunity for false negatives. If a patient with the disease tests negative on the second test, they are incorrectly classified as disease-free, reducing the overall sensitivity. Net Specificity: The overall specificity increases because the second test provides an additional opportunity to correctly identify individuals without the disease. If a patient without the disease tests negative on the second test, they are correctly classified as disease-free, enhancing the overall specificity. Incorrect Options: Option A (Net sensitivity and net specificity are both increased): This is incorrect because while specificity increases due to the second test, sensitivity decreases because of the potential for false negatives introduced by the second test. Option C (Net sensitivity is increased and net specificity is increased): This is incorrect because the second test can decrease sensitivity due to additional false negatives, even though it increases specificity. Option D (Net sensitivity remains the same and net specificity is increased): This is incorrect because the second test can decrease sensitivity due to additional false negatives, even though it increases specificity.",
      "correct_choice_id": 220728,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41272871701695070/41272871701695070.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41272871701695070/41272871701695070.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90222,
      "choices": [
        {
          "id": 220731,
          "text": "The specificity of the test is lower in population A"
        },
        {
          "id": 220732,
          "text": "The prevalence of disease is lower in population A"
        },
        {
          "id": 220733,
          "text": "The prevalence of disease is higher in population A"
        },
        {
          "id": 220734,
          "text": "The specificity of the test is higher in population A"
        }
      ],
      "text": "A screening test is used in same way in two similar population but the proportion of false positive result among population A is higher than those who test positive in population B. what is the likely explanation for this finding",
      "unique_key": "Q9314821",
      "question_audio": null,
      "question_video": null,
      "map_id": 34203368,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (The prevalence of disease is lower in population A). Understanding the Impact of Disease Prevalence on False Positives: In screening tests, the false positive rate is influenced by the specificity of the test and the prevalence of the disease in the population. Specificity refers to the test's ability to correctly identify individuals without the disease. When disease prevalence is low, the number of individuals without the disease is high, leading to a higher number of false positives even if the test has high specificity. Conversely, in populations with higher disease prevalence, the proportion of individuals without the disease decreases, resulting in fewer false positives. Applying This to the Given Scenario: In the scenario, both populations A and B are similar, and the screening test is used in the same way. However, population A has a higher proportion of false positive results among those who test positive compared to population B. This suggests that the specificity of the test is lower in population A, leading to more false positives. A lower specificity means that the test is less accurate in correctly identifying individuals without the disease, resulting in more false positives. Incorrect Options: Option A (The specificity of the test is lower in population A): This is incorrect because a lower specificity would lead to more false positives, not a higher proportion of false positives among those who test positive. Option C (The prevalence of disease is higher in population A): This is incorrect because a higher disease prevalence would result in a lower proportion of false positives among those who test positive, not a higher proportion. Option D (The specificity of the test is higher in population A): This is incorrect because a higher specificity would lead to fewer false positives, not a higher proportion of false positives among those who test positive.",
      "correct_choice_id": 220732,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16026561701695092/16026561701695092.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16026561701695092/16026561701695092.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90223,
      "choices": [
        {
          "id": 220735,
          "text": "Has a positive predictive value of 90%"
        },
        {
          "id": 220736,
          "text": "Has negative predictive value of 75%"
        },
        {
          "id": 220737,
          "text": "Has sensitivity of 90 %"
        },
        {
          "id": 220738,
          "text": "Has a specificity of 82.5%"
        }
      ],
      "text": "A test for hepatitis C is performed for 200 patient with biopsy proven disease and 200 patient known to be free of the disease . The test shows positive results on 180 of the patients with the disease , and negative result on 150 of the patient without the disease . Among those tested this test therefore:",
      "unique_key": "Q4204982",
      "question_audio": null,
      "question_video": null,
      "map_id": 34899986,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Has a sensitivity of 90%). Calculating Sensitivity: Sensitivity, also known as the true positive rate, measures the proportion of actual positives correctly identified by the test. It is calculated as: Sensitivity = (True Positives) / (True Positives + False Negatives) In this scenario: True Positives (TP): 180 patients with the disease who tested positive. False Negatives (FN): 200 patients with the disease minus 180 who tested positive, resulting in 20 patients who tested negative. Therefore: Sensitivity = 180 / (180 + 20) = 180 / 200 = 0.90 or 90% Incorrect Options: Option A (Has a positive predictive value of 90%): This is incorrect because the positive predictive value (PPV) depends on both the test's sensitivity and specificity, as well as the prevalence of the disease in the population. Without information on specificity and disease prevalence, we cannot determine the PPV. Option B (Has negative predictive value of 75%): This is incorrect because the negative predictive value (NPV) also depends on sensitivity, specificity, and disease prevalence. Given the available information, we cannot accurately calculate the NPV. Option D (Has a specificity of 82.5%): This is incorrect because specificity measures the proportion of actual negatives correctly identified by the test. To calculate specificity, we need the number of true negatives (TN) and false positives (FP). The provided information does not include these values, so we cannot determine specificity.",
      "correct_choice_id": 220737,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60693791701695106/60693791701695106.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/60693791701695106/60693791701695106.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90224,
      "choices": [
        {
          "id": 220739,
          "text": "Its sensitivity has increased"
        },
        {
          "id": 220740,
          "text": "Its positive predictive value has increased"
        },
        {
          "id": 220741,
          "text": "Its negative predictive value has increased"
        },
        {
          "id": 220742,
          "text": "The test characteristic have not changed"
        }
      ],
      "text": "Due to an effective prevention program the prevalence of an infectious disease in a community has been reduced by 90%. Physician continues to use the same diagnostic test for the disease that she has always used how have the test’s characteristics changed :",
      "unique_key": "Q4372050",
      "question_audio": null,
      "question_video": null,
      "map_id": 34026727,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Its negative predictive value has increased). Understanding the Impact of Disease Prevalence on Test Characteristics: The negative predictive value (NPV) of a diagnostic test is the probability that individuals with a negative test result truly do not have the disease. NPV is influenced by the prevalence of the disease in the population: Higher Prevalence: When a disease is more common, the proportion of true negatives decreases, which can lower the NPV. Lower Prevalence: Conversely, when a disease is less common, the proportion of true negatives increases, which can raise the NPV. In this scenario, the effective prevention program has reduced the disease prevalence by 90%, leading to a higher proportion of true negatives. As a result, the NPV of the test increases, meaning that a negative test result is more likely to accurately indicate the absence of the disease. Incorrect Options: Option A (Its sensitivity has increased): Sensitivity, which measures the proportion of actual positives correctly identified by the test, is an inherent characteristic of the test and does not change with disease prevalence. CMAJ Option B (Its positive predictive value has increased): The positive predictive value (PPV) is the probability that individuals with a positive test result truly have the disease. PPV is influenced by disease prevalence, but in this case, the significant reduction in prevalence would likely decrease the PPV, not increase it. Option D (The test characteristics have not changed): While the inherent properties of the test, such as sensitivity and specificity, remain constant, the predictive values (NPV and PPV) are affected by disease prevalence. Therefore, the test's characteristics, specifically its NPV, have changed.",
      "correct_choice_id": 220741,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70833551701695120/70833551701695120.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70833551701695120/70833551701695120.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90225,
      "choices": [
        {
          "id": 220743,
          "text": "Increasing the positive predictive value"
        },
        {
          "id": 220744,
          "text": "Increasing the negative predictive value"
        },
        {
          "id": 220745,
          "text": "Increasing the pre test odds"
        },
        {
          "id": 220746,
          "text": "Increasing the specificity"
        }
      ],
      "text": "For the diagnosis of Deep vein thrombosis 2 tests are done together namely impedence plethysmography and leg scanning after injecting 125I fibrinogen. This process will lead to:",
      "unique_key": "Q6127643",
      "question_audio": null,
      "question_video": null,
      "map_id": 34500035,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Increasing the negative predictive value). Understanding Negative Predictive Value (NPV): The negative predictive value of a diagnostic test is the probability that individuals with a negative test result truly do not have the disease. NPV is influenced by the prevalence of the disease in the population: • Higher Prevalence: When a disease is more common, the proportion of true negatives decreases, which can lower the NPV. • Lower Prevalence: Conversely, when a disease is less common, the proportion of true negatives increases, which can raise the NPV. In this scenario, the effective prevention program has reduced the disease prevalence by 90%, leading to a higher proportion of true negatives. As a result, the NPV of the test increases, meaning that a negative test result is more likely to accurately indicate the absence of the disease. Incorrect Options: Option A (Increasing the positive predictive value): The positive predictive value (PPV) is the probability that individuals with a positive test result truly have the disease. PPV is influenced by disease prevalence, but in this case, the significant reduction in prevalence would likely decrease the PPV, not increase it. Option C (Increasing the pre-test odds): The pre-test odds refer to the likelihood of a patient having the disease before any testing is done. This is determined by the disease prevalence in the population and is not directly affected by the use of diagnostic tests. Option D (Increasing the specificity): The specificity of a test, which measures the proportion of actual negatives correctly identified, is an inherent characteristic of the test and does not change with disease prevalence.",
      "correct_choice_id": 220744,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24887351703747674/24887351703747674.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24887351703747674/24887351703747674.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90226,
      "choices": [
        {
          "id": 220747,
          "text": "Sensitivity = 1 - specificity"
        },
        {
          "id": 220748,
          "text": "Positive predictive value = 1- negative predictive value"
        },
        {
          "id": 220749,
          "text": "Sensitive is inversely proportional to specificity"
        },
        {
          "id": 220750,
          "text": "Sensitivity = 1- positive predictive value"
        }
      ],
      "text": "Which one of the following relationship shown between different parameter of a performance of a test is correct :",
      "unique_key": "Q4574776",
      "question_audio": null,
      "question_video": null,
      "map_id": 34930627,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Sensitivity is inversely proportional to specificity). Understanding the Relationship Between Sensitivity and Specificity: Sensitivity and specificity are fundamental metrics used to evaluate the performance of diagnostic tests: • Sensitivity (True Positive Rate) measures the proportion of actual positives correctly identified by the test. • Specificity (True Negative Rate) measures the proportion of actual negatives correctly identified by the test. While sensitivity and specificity are independent characteristics of a test, there is often a trade-off between them. Increasing the sensitivity of a test (by lowering the threshold for a positive result) can lead to a decrease in specificity, and vice versa. This inverse relationship means that optimizing one may compromise the other. Incorrect Options: Option A (Sensitivity = 1 - specificity): This equation is incorrect. Sensitivity and specificity are independent measures and do not have a direct mathematical relationship where one equals 1 minus the other. Option B (Positive predictive value = 1 - negative predictive value): This statement is incorrect. Positive predictive value (PPV) and negative predictive value (NPV) are distinct metrics that depend on sensitivity, specificity, and disease prevalence. They are not complementary in the manner suggested by this equation. Option D (Sensitivity = 1 - positive predictive value): This equation is incorrect. Sensitivity and positive predictive value are separate metrics that do not have a direct inverse relationship. Sensitivity measures the proportion of actual positives correctly identified, while PPV measures the proportion of positive test results that are true positives.",
      "correct_choice_id": 220749,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26127561703747692/26127561703747692.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26127561703747692/26127561703747692.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90227,
      "choices": [
        {
          "id": 220751,
          "text": "Sensitivity"
        },
        {
          "id": 220752,
          "text": "Specificity"
        },
        {
          "id": 220753,
          "text": "Reliability"
        },
        {
          "id": 220754,
          "text": "Predictive value"
        }
      ],
      "text": "The usefulness of a screening test in a community depends on its",
      "unique_key": "Q4260642",
      "question_audio": null,
      "question_video": null,
      "map_id": 34203650,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Sensitivity). Understanding Sensitivity in Screening Tests: Sensitivity refers to a test's ability to correctly identify individuals who have the disease, minimizing false negatives. In a community screening context, a highly sensitive test ensures that most individuals with the disease are detected, which is crucial for early intervention and effective disease control. While specificity (the ability to correctly identify those without the disease) and predictive values are important, sensitivity is paramount in screening to ensure that as many cases as possible are identified. Incorrect Options: Option B (Specificity): While specificity is important, especially in confirmatory testing to avoid false positives, it is not the primary concern in initial screening. Screening tests prioritize sensitivity to ensure that most individuals with the disease are identified. Option C (Reliability): Reliability refers to the consistency of a test's results over time. While important, it does not directly impact the effectiveness of a screening program as much as sensitivity does. Option D (Predictive value): Predictive values depend on both the test's characteristics and the disease prevalence in the population. They are more relevant in diagnostic settings rather than initial screening.",
      "correct_choice_id": 220751,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33114691703747704/33114691703747704.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33114691703747704/33114691703747704.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90228,
      "choices": [
        {
          "id": 220755,
          "text": "54.3"
        },
        {
          "id": 220756,
          "text": "45.7"
        },
        {
          "id": 220757,
          "text": "15.3"
        },
        {
          "id": 220758,
          "text": "98.5"
        }
      ],
      "text": "In a population of 10,000 people, the prevalence of a disease is 20%. The sensitivity of a screening test is 95% and specificity is 80%. The PPV of test will be",
      "unique_key": "Q9238129",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707962,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (54.3%). Understanding Positive Predictive Value (PPV): Positive Predictive Value (PPV) is the probability that individuals with a positive test result truly have the disease. It is calculated using the formula: PPV = (Sensitivity × Prevalence) / (Sensitivity × Prevalence) + ((1-Specificity) × (1-Prevalence)) Given Data: • Prevalence: 20% (0.20) • Sensitivity: 95% (0.95) • Specificity: 80% (0.80) Calculation: Calculate the proportion of true positives (TP): TP = Sensitivity × Prevalence = 0.95 × 0.20 = 0.19 Calculate the proportion of false positives (FP): FP = (1-Specificity) × (1-Prevalence) = (1-0.80) × (1-0.20) = 0.20 × 0.80 = 0.16 Calculate the PPV: PPV = TP / TP + FP = 0.19/ 0.19 + 0.16 = 0.19 / 0.35 = 0.5429 Convert to percentage: 0.5429 ×100 = 54.3 % Incorrect Options: Option B (45.7%): This value does not correspond to the correct calculation of PPV based on the given data. Option C (15.3%): This value does not match the expected PPV for the provided sensitivity, specificity, and prevalence. Option D (98.5%): This value is significantly higher than the calculated PPV, indicating a miscalculation or misunderstanding.",
      "correct_choice_id": 220755,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15062281703747717/15062281703747717.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15062281703747717/15062281703747717.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90229,
      "choices": [
        {
          "id": 220759,
          "text": "High prevalence"
        },
        {
          "id": 220760,
          "text": "Low prevalence"
        },
        {
          "id": 220761,
          "text": "High sensitivity"
        },
        {
          "id": 220762,
          "text": "High specificity"
        }
      ],
      "text": "A test has high false positive rate in a community . True is :",
      "unique_key": "Q8295202",
      "question_audio": null,
      "question_video": null,
      "map_id": 34594004,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Low prevalence). Understanding the Relationship Between False Positive Rate and Disease Prevalence: The false positive rate refers to the proportion of individuals without the disease who incorrectly test positive. In a population with low disease prevalence, the number of individuals without the disease is high. Even with a test that has a moderate false positive rate, the absolute number of false positives can be substantial. This results in a higher proportion of false positives among those who test positive, leading to a lower positive predictive value (PPV). Conversely, in a population with high disease prevalence, the number of individuals with the disease is higher, which can reduce the proportion of false positives among those who test positive, thereby increasing the PPV. Incorrect Options: Option A (High prevalence): In a high prevalence setting, the number of true positives increases, which can reduce the proportion of false positives among those who test positive, leading to a higher PPV. Therefore, a high false positive rate is less likely in such populations. Option C (High sensitivity): Sensitivity refers to the ability of a test to correctly identify those with the disease. While high sensitivity reduces false negatives, it does not directly affect the false positive rate. Option D (High specificity): Specificity refers to the ability of a test to correctly identify those without the disease. High specificity reduces false positives, so a high false positive rate would be less likely in such cases.",
      "correct_choice_id": 220760,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34479511703747736/34479511703747736.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34479511703747736/34479511703747736.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90230,
      "choices": [
        {
          "id": 220763,
          "text": "True positive"
        },
        {
          "id": 220764,
          "text": "True negative"
        },
        {
          "id": 220765,
          "text": "False positive"
        },
        {
          "id": 220766,
          "text": "False negative"
        }
      ],
      "text": "A graph showing curves of Normal blood sugar level and Diabetic sugar level is shown below. Some area is found over lapping in the two curves. Diagnostic cut off point of 120 mg/ dL is also marked what does the shaded areas (D) represent in the graph :<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/5093805Q.29.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4505074",
      "question_audio": null,
      "question_video": null,
      "map_id": 34741489,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (False negative). Understanding the Shaded Area in the Graph: In diagnostic testing, the shaded area between the curves of normal and diabetic blood sugar levels represents individuals who have blood sugar levels near the diagnostic cutoff point (120 mg/dL in this case). These individuals are at the threshold where the test may not consistently distinguish between normal and diabetic states. As a result, some individuals with diabetes may test negative (false negatives), and some without diabetes may test positive (false positives). The shaded area indicates the overlap where the test's accuracy is less reliable, leading to these misclassifications. Incorrect Options: Option A (True positive): True positives are individuals who have the disease and test positive. The shaded area represents individuals who may test negative despite having the disease, so it does not correspond to true positives. Option B (True negative): True negatives are individuals who do not have the disease and test negative. The shaded area includes individuals who may test positive despite not having the disease, so it does not correspond to true negatives. Option C (False positive): False positives are individuals who do not have the disease but test positive. While the shaded area includes individuals who may test positive, it primarily represents those who test negative despite having the disease, so it does not correspond to false positives.",
      "correct_choice_id": 220766,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24818401703747749/24818401703747749.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24818401703747749/24818401703747749.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90231,
      "choices": [
        {
          "id": 220767,
          "text": "Incidence of SLE and Predictive value of each test"
        },
        {
          "id": 220768,
          "text": "Incidence and prevalence of SLE"
        },
        {
          "id": 220769,
          "text": "Relative risk of SLE in this patient"
        },
        {
          "id": 220770,
          "text": "Prior probability of each test sensitivity and specificity of each test"
        }
      ],
      "text": "You have clinically diagnosed a patient as having SLE at this point , you need to know :",
      "unique_key": "Q5525913",
      "question_audio": null,
      "question_video": null,
      "map_id": 34162655,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) (Prior probability of each test sensitivity and specificity of each test). Understanding the Importance of Prior Probability and Test Characteristics: When diagnosing a patient with Systemic Lupus Erythematosus (SLE), it's essential to consider the prior probability (pre-test probability) of the disease, which reflects the likelihood of the patient having SLE before conducting any diagnostic tests. This probability is influenced by factors such as the patient's clinical presentation, demographics, and epidemiological data. Additionally, understanding the sensitivity and specificity of each diagnostic test is crucial. Sensitivity indicates the test's ability to correctly identify those with the disease (true positives), while specificity measures its ability to correctly identify those without the disease (true negatives). These test characteristics, combined with the prior probability, help in calculating the post-test probability, which is the likelihood of the patient having the disease after considering the test results. This approach is fundamental in clinical decision-making, as it allows for a more accurate assessment of the patient's condition. Incorrect Options: Option A (Incidence of SLE and Predictive value of each test): While the incidence of SLE provides information about the rate of new cases in a population, it doesn't directly inform the individual patient's likelihood of having the disease. The predictive value of a test is influenced by the test's sensitivity, specificity, and the disease's prevalence, but without considering the prior probability, it doesn't offer a complete picture for the individual patient. Option B (Incidence and prevalence of SLE): Incidence refers to the number of new cases in a population over a specific period, and prevalence refers to the total number of cases at a given time. While these epidemiological measures are important for understanding disease burden in a population, they don't directly affect the individual patient's pre-test probability. Option C (Relative risk of SLE in this patient): Relative risk is a measure used in epidemiological studies to compare the risk of a certain event occurring in two groups. In clinical practice, the focus is on the individual patient's pre-test probability and the characteristics of the diagnostic tests to assess the likelihood of disease.",
      "correct_choice_id": 220770,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13373251703747760/13373251703747760.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13373251703747760/13373251703747760.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90232,
      "choices": [
        {
          "id": 220771,
          "text": "Survey"
        },
        {
          "id": 220772,
          "text": "Screening"
        },
        {
          "id": 220773,
          "text": "Surveillance"
        },
        {
          "id": 220774,
          "text": "Rehabilitation"
        }
      ],
      "text": "Epidemiological survey of ‘at risk’ is called :",
      "unique_key": "Q7664704",
      "question_audio": null,
      "question_video": null,
      "map_id": 34218740,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Screening). Understanding Screening in Epidemiology: In epidemiology, screening refers to the systematic application of a test or procedure to identify individuals at risk for a specific disease or health condition within a population. The primary goal of screening is to detect potential health issues before symptoms manifest, allowing for early intervention and better health outcomes. Screening is particularly valuable in identifying individuals who may not yet exhibit symptoms but are at increased risk for certain diseases. Incorrect Options: Option A (Survey): A survey is a method of data collection used to gather information from individuals or groups. While surveys can be used to collect data on health behaviors or outcomes, they are not specifically designed to identify individuals at risk for a particular disease. Option C (Surveillance): Surveillance involves the continuous, systematic collection, analysis, and interpretation of health-related data. It is used to monitor the spread of diseases, track health trends, and inform public health decisions. Unlike screening, surveillance does not involve testing individuals to identify those at risk; rather, it focuses on observing and analyzing health data over time. Option D (Rehabilitation): Rehabilitation refers to the process of restoring individuals to their optimal physical, mental, and social functioning after illness or injury. It is a therapeutic intervention aimed at helping individuals recover and regain independence, rather than identifying those at risk for diseases.",
      "correct_choice_id": 220772,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36524101703747901/36524101703747901.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36524101703747901/36524101703747901.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90233,
      "choices": [
        {
          "id": 220775,
          "text": "Sensitivity is false positive rate"
        },
        {
          "id": 220776,
          "text": "Specificity is false negative rate"
        },
        {
          "id": 220777,
          "text": "Predictive value depends on prevalence"
        },
        {
          "id": 220778,
          "text": "None of the above"
        }
      ],
      "text": "Which of the following is / are true about a screening test :",
      "unique_key": "Q6781484",
      "question_audio": null,
      "question_video": null,
      "map_id": 34911260,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Predictive value depends on prevalence). Understanding Predictive Value and Prevalence: The predictive value of a screening test refers to the likelihood that a person with a positive or negative test result actually has or does not have the disease, respectively. This value is influenced by the prevalence of the disease in the population being tested. As the prevalence of a disease increases, the positive predictive value (PPV) of a test also increases, meaning that a positive test result is more likely to be a true positive. Conversely, as prevalence decreases, the PPV decreases, and the negative predictive value (NPV) increases, meaning that a negative test result is more likely to be a true negative. This relationship underscores the importance of considering disease prevalence when interpreting test results. Incorrect Options: Option A (Sensitivity is false positive rate): This statement is incorrect. Sensitivity refers to the proportion of actual positives correctly identified by the test (true positives), not the false positive rate. The false positive rate is actually 1 minus the specificity of the test. Option B (Specificity is false negative rate): This statement is also incorrect. Specificity refers to the proportion of actual negatives correctly identified by the test (true negatives), not the false negative rate. The false negative rate is 1 minus the sensitivity of the test. Option D (None of the above): Since option C is correct, this option is incorrect.",
      "correct_choice_id": 220777,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7449711703747912/7449711703747912.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7449711703747912/7449711703747912.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90234,
      "choices": [
        {
          "id": 220779,
          "text": "Sensitivity is 70%"
        },
        {
          "id": 220780,
          "text": "Specificity is 80%"
        },
        {
          "id": 220781,
          "text": "Sensitivity is 90%"
        },
        {
          "id": 220782,
          "text": "NPV is 98%"
        }
      ],
      "text": "A city has a population of 10000 with 500 diabetic patients. A new diagnostic test gives true positive result in 350 patients and false positive result in 1900 patient which of the following is false regarding the test",
      "unique_key": "Q4617643",
      "question_audio": null,
      "question_video": null,
      "map_id": 34547283,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Sensitivity is 90%). Calculating Sensitivity, Specificity, and Negative Predictive Value (NPV): Given the following data: • Total population: 10,000 • Diabetic patients (disease present): 500 • True positives (TP): 350 • False positives (FP): 1,900 1. Sensitivity: Sensitivity measures the proportion of actual positives correctly identified by the test. Sensitivity = True Positives / True Positives + False Negatives Since the total number of diabetic patients is 500, and 350 are correctly identified as positive, the remaining 150 are false negatives. Sensitivity = 350 / 350 + 150 = 350/500 = 70% 2. Specificity: Specificity measures the proportion of actual negatives correctly identified by the test. Specificity = True Negatives / True Negatives + False Positives The total number of non-diabetic patients is 9,500 (10,000 total population minus 500 diabetic patients). Specificity = 9,500 - 1,900 / 9,500 = 7,600 / 9,500 = 80% 3. Negative Predictive Value (NPV): NPV measures the proportion of negative test results that are true negatives. NPV = True Negatives / True Negatives + False Negatives NPV = 7,600 / 7,600 + 150 = 7,600 / 7,750 = 98 % Incorrect Options: Option A (Sensitivity is 70%): This statement is correct, as calculated above. Option B (Specificity is 80%): This statement is correct, as calculated above. Option D (NPV is 98%): This statement is correct, as calculated above.",
      "correct_choice_id": 220781,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46837021703747933/46837021703747933.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46837021703747933/46837021703747933.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90235,
      "choices": [
        {
          "id": 220783,
          "text": "Specificity"
        },
        {
          "id": 220784,
          "text": "Sensitivity"
        },
        {
          "id": 220785,
          "text": "Reliability"
        },
        {
          "id": 220786,
          "text": "Predictive value"
        }
      ],
      "text": "Most important factor for a test to be a good screening test is :",
      "unique_key": "Q1560265",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985862,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Sensitivity). Understanding Sensitivity in Screening Tests: Sensitivity refers to a test's ability to correctly identify individuals who have the disease, minimizing false negatives. In screening, it's crucial to detect as many true cases as possible to ensure early intervention. A highly sensitive test ensures that most individuals with the disease are identified, which is vital for conditions where early treatment can significantly improve outcomes. Incorrect Options: Option A (Specificity): While specificity, which measures a test's ability to correctly identify individuals without the disease, is important to reduce false positives, it is secondary to sensitivity in screening. In screening, the priority is to identify as many true cases as possible, even if it means accepting some false positives. Option C (Reliability): Reliability refers to the consistency of a test's results over time. While important, it is not the most critical factor in screening. A test can be reliable but not sensitive enough to detect all true cases, which is more detrimental in a screening context. Option D (Predictive Value): Predictive value depends on both the test's characteristics and the disease prevalence in the population. While important, it is not the most critical factor in screening. A test with high sensitivity is more crucial for effective screening, as it ensures that most individuals with the disease are identified.",
      "correct_choice_id": 220784,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5335211703747952/5335211703747952.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5335211703747952/5335211703747952.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90236,
      "choices": [
        {
          "id": 220787,
          "text": "Sensitivity increase"
        },
        {
          "id": 220788,
          "text": "Specificity decrease"
        },
        {
          "id": 220789,
          "text": "Increase positive predictive value"
        },
        {
          "id": 220790,
          "text": "Decrease positive predictive value"
        }
      ],
      "text": "If prevalence is increased which of the following will be seen :",
      "unique_key": "Q7746556",
      "question_audio": null,
      "question_video": null,
      "map_id": 34122077,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (Increase positive predictive value). Understanding the Impact of Increased Prevalence on Predictive Values: When the prevalence of a disease increases in a population, the positive predictive value (PPV) of a diagnostic test also increases. PPV represents the probability that individuals with a positive test result actually have the disease. Higher disease prevalence means that a larger proportion of individuals in the population have the disease, making a positive test result more likely to be a true positive. This relationship underscores the importance of considering disease prevalence when interpreting test results. Incorrect Options: Option A (Sensitivity increase): Sensitivity, which measures the proportion of actual positives correctly identified by the test, is an inherent characteristic of the test and is not directly affected by disease prevalence. An increase in prevalence does not change the test's sensitivity. Option B (Specificity decrease): Specificity, which measures the proportion of actual negatives correctly identified by the test, is also an inherent characteristic of the test and is not directly influenced by disease prevalence. An increase in prevalence does not affect the test's specificity. Option D (Decrease positive predictive value): As explained above, an increase in disease prevalence actually leads to an increase in PPV, not a decrease.",
      "correct_choice_id": 220789,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50954481703747995/50954481703747995.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50954481703747995/50954481703747995.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90237,
      "choices": [
        {
          "id": 220791,
          "text": "Sensitivity 70%"
        },
        {
          "id": 220792,
          "text": "Specificity 70%"
        },
        {
          "id": 220793,
          "text": "Sensitivity 80%"
        },
        {
          "id": 220794,
          "text": "Specificity 80%"
        }
      ],
      "text": "5000 persons underwent screening for a disease. Out of 500 diseased, 350 reported true positive and out of 4500 health 3000 reported true negative . Which of the following is correct about this screening test :",
      "unique_key": "Q5506645",
      "question_audio": null,
      "question_video": null,
      "map_id": 34702818,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Sensitivity 70%). Calculating Sensitivity and Specificity: Given the following data: • Total population: 5,000 • Diseased individuals (disease present): 500 • True positives (TP): 350 • Healthy individuals (disease absent): 4,500 • True negatives (TN): 3,000 1. Sensitivity: Sensitivity measures the proportion of actual positives correctly identified by the test. Sensitivity = True Positives / True Positives + False Negatives Since the total number of diseased individuals is 500, and 350 are correctly identified as positive, the remaining 150 are false negatives. Sensitivity = 350 / 350 + 150 = 350 / 500 = 70% 2. Specificity: Specificity measures the proportion of actual negatives correctly identified by the test. Specificity = True Negatives / True Negatives + False Positives The total number of healthy individuals is 4,500, and 3,000 are correctly identified as negative, so the remaining 1,500 are false positives. Specificity = 3,000 / 3,000 + 1,500 = 3,000 / 4,500 = 66.67% Incorrect Options: Option B (Specificity 70%): This statement is incorrect. As calculated above, the specificity is approximately 66.67%, not 70%. Option C (Sensitivity 80%): This statement is incorrect. As calculated above, the sensitivity is 70%, not 80%. Option D (Specificity 80%): This statement is incorrect. As calculated above, the specificity is approximately 66.67%, not 80%.",
      "correct_choice_id": 220791,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74381701703748009/74381701703748009.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74381701703748009/74381701703748009.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90238,
      "choices": [
        {
          "id": 220795,
          "text": "Less than 50%"
        },
        {
          "id": 220796,
          "text": "70"
        },
        {
          "id": 220797,
          "text": "95%"
        },
        {
          "id": 220798,
          "text": "72%"
        }
      ],
      "text": "A diagnostic test for a particular disease has a sensitivity of 0.90 and a specificity of 0.80 . A single test is applied to each subject in the population in which the disease population is 30% what is the probability that a person . Negative to this test has no disease :",
      "unique_key": "Q9174858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34423896,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) (95%). Understanding Negative Predictive Value (NPV): The Negative Predictive Value (NPV) represents the probability that individuals with a negative test result truly do not have the disease. It is influenced by the test's specificity and the disease prevalence in the population. Given: • Sensitivity (True Positive Rate): 0.90 • Specificity (True Negative Rate): 0.80 • Prevalence (Disease Prevalence): 30% or 0.30 • Calculating NPV: The formula for NPV is: NPV = Specificity × (1-Prevalence) / [Specificity × (1-Prevalence)] + [(1-Sensitivity) × Prevalence] Substituting the given values: NPV = 0.80 × (1-0.30) / (0.80 × (1-0.30)) + ((1-0.90) × 0.30) NPV = 0.80 × 0.70 / (0.80 × 0.70) + (0.10 × 0.30) NPV = 0.56 / 0.56 + 0.03 NPV = 0.56 / 0.59 NPV = 0.949 NPV = 95% Incorrect Options: Option A (Less than 50%): This is incorrect. The NPV is approximately 95%, which is much higher than 50%. Option B (70): This is incorrect. The NPV is approximately 95%, not 70. Option D (72%): This is incorrect. The NPV is approximately 95%, not 72%.",
      "correct_choice_id": 220797,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72291851703748023/72291851703748023.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72291851703748023/72291851703748023.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90239,
      "choices": [
        {
          "id": 220799,
          "text": "Number of true negatives + number of false negatives"
        },
        {
          "id": 220800,
          "text": "Number of true positive + number of true negative"
        },
        {
          "id": 220801,
          "text": "Number of true positive + number of false positive"
        },
        {
          "id": 220802,
          "text": "Number of true positive + number of false negative"
        }
      ],
      "text": "Denominator of negative predictive value :",
      "unique_key": "Q8079172",
      "question_audio": null,
      "question_video": null,
      "map_id": 34508483,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Number of true negatives + number of false negatives). Understanding Negative Predictive Value (NPV): The Negative Predictive Value (NPV) represents the probability that individuals with a negative test result truly do not have the disease. It is calculated using the formula: NPV = True Negatives / True Negatives + False Negatives In this formula, the denominator includes all individuals who received a negative test result, which consists of both true negatives and false negatives. Incorrect Options: Option B (Number of true positives + number of true negatives): This combination represents all individuals who received a positive test result, not those who tested negative. Option C (Number of true positives + number of false positives): This combination represents all individuals who received a positive test result, not those who tested negative. Option D (Number of true positives + number of false negatives): This combination represents all individuals who have the disease, regardless of their test result.",
      "correct_choice_id": 220799,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63012831703748049/63012831703748049.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63012831703748049/63012831703748049.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90240,
      "choices": [
        {
          "id": 220803,
          "text": "Sensitivity 90 specificity 90"
        },
        {
          "id": 220804,
          "text": "Sensitivity 95 specificity 90"
        },
        {
          "id": 220805,
          "text": "Sensitivity 90 specificity 95"
        },
        {
          "id": 220806,
          "text": "Sensitivity 95 specificity 95"
        }
      ],
      "text": "Calculate sensitivity and specificity based on following table<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/2944023Q.39.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1540854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34620808,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) To calculate sensitivity and specificity, we use the following formulas: 1. Sensitivity: Proportion of true positives correctly identified by the test. Sensitivity=True Positives (TP) / True Positives (TP) + False Negatives (FN) X 100 2. Specificity: Proportion of true negatives correctly identified by the test. Specificity= True Negatives (TN) / True Negatives (TN) + False Positives (FP) X 100 From the table: • Diseased (TP + FN): Test Positive = 27, Test Negative = 3 - True Positives (TP) = 27 - False Negatives (FN) = 3 • Non-diseased (TN + FP): Test Positive = 5, Test Negative = 95 - False Positives (FP) = 5 - True Negatives (TN) = 95 Step-by-step Calculation: Sensitivity: Sensitivity=TP/TP+FN X 100 Sensitivity=27/ 27+3 X 100 = 27/30 X 100 = 90% Specificity: Specificity= TN/TN+FP X 100 Specificity=95/95+5 X 100= 95/100 X 100 = 95% Correct Answer: C (Sensitivity 90%, Specificity 95%) Incorrect Options: 1. A (Sensitivity 90%, Specificity 90%): - Sensitivity is correct at 90%, but specificity is not 90%; it is 95%. 2. B (Sensitivity 95%, Specificity 90%): - Specificity is correct at 95%, but sensitivity is not 95%; it is 90%. 3. D (Sensitivity 95%, Specificity 95%): - Both sensitivity and specificity are not 95%; sensitivity is 90%, and specificity is 95%.",
      "correct_choice_id": 220805,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/758401703748072/758401703748072.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/758401703748072/758401703748072.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90241,
      "choices": [
        {
          "id": 220807,
          "text": "Person have disease but show negative test result"
        },
        {
          "id": 220808,
          "text": "Person have no disease but shows negative test"
        },
        {
          "id": 220809,
          "text": "Person have disease but show positive test result"
        },
        {
          "id": 220810,
          "text": "Person have no disease but show positive test result"
        }
      ],
      "text": "False negative means :",
      "unique_key": "Q3629137",
      "question_audio": null,
      "question_video": null,
      "map_id": 34753060,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) A person has the disease but shows a negative test result. A false negative occurs when a test fails to identify the presence of a disease in an individual who actually has it. This means the test result incorrectly indicates that the person does not have the disease, potentially delaying diagnosis and treatment. This is the definition of a false negative. In diagnostic testing: A false negative result implies that the test failed to detect the condition it was designed to identify. For example, if someone has COVID-19 but the test returns a negative result, that is a false negative. False negatives are critical to avoid, especially in serious diseases, as they may lead to missed treatment opportunities and further complications. Incorrect Options: B (Person has no disease but shows a negative test result): This describes a true negative, where the test correctly identifies a person as not having the disease. Since the individual does not have the disease and the test shows a negative result, there is no error in the test outcome. C (Person has disease but shows a positive test result): This describes a true positive, where the test correctly identifies the disease in an individual who has it. There is no error in the test outcome in this scenario. D (Person has no disease but shows a positive test result): This describes a false positive, where the test incorrectly identifies the disease in an individual who does not actually have it. False positives may lead to unnecessary anxiety and additional testing but are not the same as a false negative.",
      "correct_choice_id": 220807,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35588061703748088/35588061703748088.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35588061703748088/35588061703748088.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90242,
      "choices": [
        {
          "id": 220811,
          "text": "ROC Curve"
        },
        {
          "id": 220812,
          "text": "Frequency polygon"
        },
        {
          "id": 220813,
          "text": "Histogram"
        },
        {
          "id": 220814,
          "text": "Scatter Diagram"
        }
      ],
      "text": "Threshold of measurable data can be determined by :",
      "unique_key": "Q4105611",
      "question_audio": null,
      "question_video": null,
      "map_id": 34700160,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) ROC Curve. The Receiver Operating Characteristic (ROC) Curve is a graphical representation used to determine the optimal threshold for distinguishing between two conditions, such as the presence or absence of a disease. It is widely used in diagnostic testing to evaluate the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By analyzing the ROC curve, one can identify the threshold that provides the best balance between sensitivity and specificity. The ROC curve helps in determining the optimal cutoff point for a diagnostic test or measurable data. Each point on the ROC curve corresponds to a different threshold, and the curve allows comparison of the sensitivity and specificity for different thresholds. The area under the curve (AUC) measures the overall accuracy of the test. For example, in a glucose tolerance test, the ROC curve can help decide the best glucose level threshold to diagnose diabetes. Incorrect Options: B (Frequency polygon): A frequency polygon is a graph that represents the distribution of data by plotting frequency counts at the midpoint of intervals. It is used to visualize patterns in the data, such as distribution shapes, but it cannot determine the threshold of measurable data. C (Histogram): A histogram is a graphical representation of data using bars to show frequency distributions. While it provides insights into the data distribution, it does not help in determining the threshold for a specific diagnostic or measurement test. D (Scatter Diagram): A scatter diagram is used to display the relationship or correlation between two continuous variables. It does not assist in finding thresholds but is useful for understanding trends or associations between variables.",
      "correct_choice_id": 220811,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78651691703748101/78651691703748101.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78651691703748101/78651691703748101.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90243,
      "choices": [
        {
          "id": 220815,
          "text": "Sensitivity & specificity"
        },
        {
          "id": 220816,
          "text": "(1-sensitivity) & specificity"
        },
        {
          "id": 220817,
          "text": "Sensitivity & (1 - specificity)"
        },
        {
          "id": 220818,
          "text": "(1-sensivity) & ( 1- specificity)"
        }
      ],
      "text": "Receiver operator characteristic (ROC) curve is usually drawn between:",
      "unique_key": "Q5495033",
      "question_audio": null,
      "question_video": null,
      "map_id": 34580542,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Sensitivity & (1 - Specificity). The Receiver Operating Characteristic (ROC) curve is a plot that helps assess the performance of a diagnostic test by illustrating the trade-off between sensitivity (True Positive Rate) and (1 - Specificity), also known as the False Positive Rate. The x-axis of the ROC curve represents the False Positive Rate (1 - Specificity). False Positive Rate = 1-Specificity This measures how often the test incorrectly identifies a negative case as positive. The y-axis represents the True Positive Rate (Sensitivity). Sensitivity measures the proportion of actual positive cases correctly identified by the test. Each point on the ROC curve corresponds to a different threshold value, and the curve shows the trade-off between sensitivity and false positives for these thresholds. The closer the curve is to the top-left corner, the better the test's performance. Incorrect Options: A (Sensitivity & Specificity): Sensitivity and specificity are not plotted against each other in an ROC curve. Instead, specificity is indirectly included as 1-Specificity which forms the x-axis. B (1 - Sensitivity & Specificity): This is incorrect because 1 - Sensitivity represents the False Negative Rate, which is not plotted in an ROC curve. Specificity is also not directly plotted. D (1 - Sensitivity & 1 - Specificity): This is incorrect because plotting both false negative rate (1 - Sensitivity) and false positive rate (1 - Specificity) would not provide the information needed for a ROC curve.",
      "correct_choice_id": 220817,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58978221703748117/58978221703748117.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58978221703748117/58978221703748117.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90244,
      "choices": [
        {
          "id": 220819,
          "text": "0.5"
        },
        {
          "id": 220820,
          "text": "0.9"
        },
        {
          "id": 220821,
          "text": "0.83"
        },
        {
          "id": 220822,
          "text": "-0.064"
        }
      ],
      "text": "A screening test was positive in 50% of diseased and 10% of healthy population what is the specificity of the test :",
      "unique_key": "Q6557331",
      "question_audio": null,
      "question_video": null,
      "map_id": 34398771,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (0.9) To calculate specificity, we use the formula: Specificity=True Negatives (TN) / True Negatives (TN) + False Positives (FP) Specificity measures the proportion of healthy individuals (non-diseased) who are correctly identified as negative by the test. Given Information: - The test is positive in 10% of the healthy population (False Positive Rate = 10%). - Therefore, True Negative Rate (Specificity) = 1-False Positive Rate=1-0.1=0.9 The specificity of the test is 0.9 (90%) because it correctly identifies 90% of healthy individuals as negative. Incorrect Options: A (0.5): A specificity of 0.5 (50%) would indicate that the test is no better than random chance in identifying healthy individuals, which is not supported by the data. C (0.83): A specificity of 0.83 (83%) is lower than the calculated value of 0.9, so it is incorrect. D (-0.064): Specificity cannot be negative, as it represents a proportion or percentage. This value is invalid.",
      "correct_choice_id": 220820,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41159991703748133/41159991703748133.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41159991703748133/41159991703748133.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90245,
      "choices": [
        {
          "id": 220823,
          "text": "Breast"
        },
        {
          "id": 220824,
          "text": "Colon"
        },
        {
          "id": 220825,
          "text": "Cervix"
        },
        {
          "id": 220826,
          "text": "Lung"
        }
      ],
      "text": "Screening in general population done in cancers of all except:",
      "unique_key": "Q6223147",
      "question_audio": null,
      "question_video": null,
      "map_id": 34481497,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Of all the options given lung cancer is the least preferred option as for lung cancer screening tool is HRCT which is not possible at the community level",
      "correct_choice_id": 220826,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26605711703748149/26605711703748149.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26605711703748149/26605711703748149.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90246,
      "choices": [
        {
          "id": 220827,
          "text": "Diabetes mellitus"
        },
        {
          "id": 220828,
          "text": "Carcinoma cervix"
        },
        {
          "id": 220829,
          "text": "Refractive errors"
        },
        {
          "id": 220830,
          "text": "Dental malocclusion"
        }
      ],
      "text": "Not a part national screening program is:",
      "unique_key": "Q3827232",
      "question_audio": null,
      "question_video": null,
      "map_id": 34667619,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Dental malocclusion. National screening programs focus on conditions that have significant public health importance, meet specific screening criteria (e.g., early detection improves outcomes), and are prevalent in the population. Conditions like diabetes mellitus, carcinoma cervix, and refractive errors are included in various national health programs due to their high prevalence and impact on health, whereas dental malocclusion is not part of any national screening program. Dental malocclusion is not considered a priority for national screening programs because: - It is not a significant public health issue in terms of morbidity or mortality. - It does not fulfill the criteria for large-scale screening, as it does not usually lead to severe health complications. - Treatment is often elective (orthodontics) and focused on improving aesthetics and functionality rather than preventing severe disease. Incorrect Options: A (Diabetes mellitus): Diabetes is part of national screening programs worldwide due to its high prevalence and severe complications, such as cardiovascular disease, nephropathy, and retinopathy. Early detection through programs like noncommunicable disease screening allows timely intervention to prevent complications. B (Carcinoma cervix): Cervical cancer screening is a major part of national health programs, particularly in the form of Pap smears and HPV testing. Early detection significantly reduces cervical cancer mortality rates. C (Refractive errors): Refractive error screening, especially in children, is included in school health programs and other national initiatives to prevent avoidable vision impairment and improve educational outcomes.",
      "correct_choice_id": 220830,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1025371703748170/1025371703748170.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1025371703748170/1025371703748170.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90247,
      "choices": [
        {
          "id": 220831,
          "text": "Ca colon"
        },
        {
          "id": 220832,
          "text": "Breast Ca"
        },
        {
          "id": 220833,
          "text": "Ca Pancreas"
        },
        {
          "id": 220834,
          "text": "Ca cervix"
        }
      ],
      "text": "Screening is not useful for",
      "unique_key": "Q2019091",
      "question_audio": null,
      "question_video": null,
      "map_id": 34173431,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Ca Pancreas. Screening is most effective for cancers that are: Common in the population. Detectable at an early stage through effective screening methods. Treatable in the early stages, with improved outcomes due to early detection. Pancreatic cancer does not meet these criteria for general population screening, making screening ineffective. Pancreatic cancer is often asymptomatic until it has reached an advanced stage, and there is currently no reliable, widely accepted, or cost-effective screening test for early detection in the general population. Even with early detection, the prognosis for pancreatic cancer remains poor, as it progresses aggressively and is often resistant to treatment. Screening is limited to high-risk individuals, such as those with a strong family history or genetic predisposition (e.g., BRCA mutations). Incorrect Options: A (Ca Colon): Screening for colorectal cancer is highly effective and recommended for the general population. Tests like colonoscopy, fecal occult blood tests (FOBT), and stool DNA tests can detect precancerous polyps or early-stage cancer, significantly improving survival rates. B (Breast Ca): Breast cancer screening through mammography is a key component of national health programs and has been shown to reduce mortality by detecting cancer at an early, treatable stage. D (Ca Cervix): Screening for cervical cancer using Pap smears and HPV testing is one of the most effective public health interventions, helping to prevent the progression from precancerous lesions to invasive cancer.",
      "correct_choice_id": 220833,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75791901703748187/75791901703748187.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75791901703748187/75791901703748187.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90248,
      "choices": [
        {
          "id": 220835,
          "text": "30/ 60"
        },
        {
          "id": 220836,
          "text": "30/ 50"
        },
        {
          "id": 220837,
          "text": "70/ 90"
        },
        {
          "id": 220838,
          "text": "90/ 100"
        }
      ],
      "text": "In a test of 150 people for HIV, Western blot found that 50 people are suffering from HIV & 100 were not suffering from HIV. Out of this 50, 30 had positive results with ICT kit & only 70 were found to be negative as per the kit from the 100 labelled as negative from the western blot. What is the sensitivity for this test?",
      "unique_key": "Q4276903",
      "question_audio": null,
      "question_video": null,
      "map_id": 34252718,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Practical Approach to Question on 2 by 2 Table • Step 1: Draw the 2 by 2 table & label it • Step 2: Write the total population (if total population is not mentioned then we most commonly assume it as hundred) • Step 3: Write the column 1 total. This is obtained from 3 sources: • Prevalence • Those mentioned positive with gold standard • Those mentioned diseased • Step 4: We fill the 4 cells & apply the formula<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/5647178A.47.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 220836,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73404241703748215/73404241703748215.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73404241703748215/73404241703748215.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90249,
      "choices": [
        {
          "id": 220839,
          "text": "30/ 60"
        },
        {
          "id": 220840,
          "text": "30/ 50"
        },
        {
          "id": 220841,
          "text": "70/ 100"
        },
        {
          "id": 220842,
          "text": "70/ 90"
        }
      ],
      "text": "Calculate the PPV:<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/26443451.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1913206",
      "question_audio": null,
      "question_video": null,
      "map_id": 34249914,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/4187401.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 220840,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74546651703748231/74546651703748231.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74546651703748231/74546651703748231.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90250,
      "choices": [
        {
          "id": 220843,
          "text": "1"
        },
        {
          "id": 220844,
          "text": "2"
        },
        {
          "id": 220845,
          "text": "3.5"
        },
        {
          "id": 220846,
          "text": "6"
        }
      ],
      "text": "A virulent bacterial infection has an 80?se fatality rate if it is not identified early in its course, however prompt administration of antibiotics decreased the mortality rate to<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/5557742image.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4809486",
      "question_audio": null,
      "question_video": null,
      "map_id": 34171987,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) As the disease has high mortality; and treatment reduces the mortality to less than 5% so treatment should be initiated at start of infection that is at 2",
      "correct_choice_id": 220844,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56473091703748247/56473091703748247.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56473091703748247/56473091703748247.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90251,
      "choices": [
        {
          "id": 220847,
          "text": "Lead time"
        },
        {
          "id": 220848,
          "text": "Lead time bias"
        },
        {
          "id": 220849,
          "text": "Screening time"
        },
        {
          "id": 220850,
          "text": "None of the above"
        }
      ],
      "text": "Doctor 1 diagnoses cervical cancer using PAP smear and mean age of diagnosis is 40 years, gives available treatment and patients die at 60 years. Doctor 2 diagnoses cervical cancer using a new screening test (Y) and mean age of diagnosis is 35 years, gives available treatment and patients die at 60 years. As compared to the doctor 1; doctor 2 has provided patient:",
      "unique_key": "Q2808702",
      "question_audio": null,
      "question_video": null,
      "map_id": 34617966,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Lead time bias. In this scenario, Doctor 2 diagnoses cervical cancer earlier (at age 35) using a new screening test (Y) compared to Doctor 1, who diagnoses it at age 40. Both doctors provide the same treatment and patients die at age 60. The earlier diagnosis through the new screening test does not improve the patient's survival but only shifts the diagnosis to an earlier point in time. This is an example of lead time bias. Lead time bias occurs when a disease is diagnosed earlier than it would have been in the absence of screening, but the earlier diagnosis does not actually improve the prognosis or life expectancy. Instead, the patient's survival appears longer just because the disease was detected earlier. Lead time bias refers to the apparent increase in survival time that results from earlier detection of a disease, without any actual improvement in the outcome (i.e., life expectancy or survival rate). In this case, Doctor 2's earlier diagnosis (35 years instead of 40 years) does not lead to improved treatment or survival; it merely shifts the point of diagnosis earlier without changing the overall survival time (which remains the same, i.e., patients die at age 60). Incorrect Options: A (Lead time): Lead time refers to the actual amount of time gained by detecting a disease earlier. In this case, Doctor 2's patients are diagnosed earlier, but there is no actual increase in survival, so the concept of lead time is not the correct choice here. Lead time would be relevant if the earlier diagnosis resulted in longer survival or earlier intervention. C (Screening time): Screening time is not a standard term in this context. It generally refers to the duration or interval over which screening is conducted. This option does not describe the situation in the question, where the key issue is the impact of early diagnosis on survival, not the duration of screening itself. D (None of the above): Since lead time bias is the correct answer, None of the above is not correct.",
      "correct_choice_id": 220848,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35930121703748263/35930121703748263.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35930121703748263/35930121703748263.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90252,
      "choices": [
        {
          "id": 220851,
          "text": "Prospective screening"
        },
        {
          "id": 220852,
          "text": "Prescriptive screening"
        },
        {
          "id": 220853,
          "text": "Mass screening"
        },
        {
          "id": 220854,
          "text": "None of the above"
        }
      ],
      "text": "All the immigrants at international airport are screened for fever to rule out COVID 19. this is example of",
      "unique_key": "Q2060601",
      "question_audio": null,
      "question_video": null,
      "map_id": 34301360,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Prospective Screening) Prospective screening refers to the process of actively screening individuals before symptoms appear, aiming to detect a disease early in people who are at risk. In this case, all immigrants at an international airport are being screened for fever to detect potential COVID-19 cases before they show symptoms or spread the infection. This forward-looking approach aligns with prospective screening, where individuals are monitored to identify disease before clinical symptoms manifest. Thus, Option A (Prospective Screening) is the correct answer. Incorrect Options: Option B (Prescriptive Screening) Prescriptive screening involves screening individuals based on specific guidelines or medical advice, often targeting high-risk groups. It is typically advised by healthcare providers based on medical history (e.g., screening high-risk individuals for diabetes or hypertension). Airport screening applies to all travelers, not a specific high-risk group, so this is not prescriptive screening. Option C (Mass Screening) Mass screening refers to screening an entire population, regardless of risk factors, such as screening all newborns for genetic disorders or all adults for hypertension. While airport screening targets all immigrants, it is not a general population screening program but rather a targeted screening for travelers, making it more prospective than mass screening. Option D (None of the above) Since prospective screening is the correct term, this option is incorrect.",
      "correct_choice_id": 220851,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11504311699350095/11504311699350095.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11504311699350095/11504311699350095.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90253,
      "choices": [
        {
          "id": 220855,
          "text": "Low sensitivity High Specificity"
        },
        {
          "id": 220856,
          "text": "Relatively cheaper"
        },
        {
          "id": 220857,
          "text": "Acceptable"
        },
        {
          "id": 220858,
          "text": "Should not be basis for treatment"
        }
      ],
      "text": "A new screening test for phenyketonuria is approved by FDA. Which of the following should not be a characteristic of this new screening test?",
      "unique_key": "Q9838898",
      "question_audio": null,
      "question_video": null,
      "map_id": 34518967,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) (Low Sensitivity, High Specificity) For a screening test, high sensitivity is crucial to ensure that most cases of the disease are detected, especially for conditions like phenylketonuria (PKU), where early detection is critical for preventing severe complications. Screening tests prioritize high sensitivity because missing cases (false negatives) could lead to untreated individuals developing severe disease. High specificity is preferred but not at the cost of sensitivity in screening settings. Since a low sensitivity test would miss many PKU cases, Option A is the incorrect characteristic and the correct answer. Incorrect Options: Option B (Relatively Cheaper) Screening tests should be cost-effective, as they are applied to large populations. A test that is too expensive may be inaccessible, making it impractical for public health programs. Since affordability is a desired feature, this is a correct characteristic of a screening test. Option C (Acceptable) A good screening test should be widely acceptable to both patients and healthcare providers. Tests that are painful, invasive, or culturally unacceptable may not be adopted, leading to poor compliance. Since acceptability is important, this is a correct characteristic of a screening test. Option D (Should Not Be Basis for Treatment) Screening identifies potential cases but does not confirm the disease; diagnostic tests are needed before treatment is started. PKU screening requires confirmatory testing (e.g., plasma phenylalanine levels). Since screening alone should not be the sole basis for treatment, this is a correct characteristic.",
      "correct_choice_id": 220855,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56213921699350108/56213921699350108.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56213921699350108/56213921699350108.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90254,
      "choices": [
        {
          "id": 220859,
          "text": "Low specificity"
        },
        {
          "id": 220860,
          "text": "Low sensitivity"
        },
        {
          "id": 220861,
          "text": "Low PPV"
        },
        {
          "id": 220862,
          "text": "High sensitivity"
        }
      ],
      "text": "Earlier for screening of tuberculosis, tuberculin test was done. If positive CXR was done. But now a days tuberculin test and CXR are done simultaneously. What were the drawback of previous guidelines?",
      "unique_key": "Q4733048",
      "question_audio": null,
      "question_video": null,
      "map_id": 34717662,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Low Sensitivity) Previously, tuberculin skin test (TST) was used as a primary screening tool, followed by a chest X-ray (CXR) only if TST was positive. The main drawback of this approach was low sensitivity, meaning many TB cases were missed due to false negatives in TST. TST can give false negatives in immunocompromised individuals, such as those with HIV, malnutrition, or recent TB infection. Sensitivity of TST is low, especially in populations where TB is endemic or in people with latent TB. By adding CXR simultaneously, more cases are detected, reducing the risk of missing infections. Thus, Option B (Low Sensitivity) is the correct answer. Incorrect Options: Option A (Low Specificity) – Incorrect TST has a reasonable specificity, though it may give false positives in BCG-vaccinated individuals or due to non-tuberculous mycobacteria (NTM) infections. The problem with the previous approach was missing cases (low sensitivity) rather than incorrect positives. Option C (Low PPV) – Incorrect Positive Predictive Value (PPV) depends on disease prevalence in the population. The previous approach still detected true TB cases but failed to identify all infected individuals due to false negatives, which is a sensitivity issue, not a PPV issue. Option D (High Sensitivity) – Incorrect If the previous approach had high sensitivity, it would have correctly identified most TB cases. However, due to false negatives with TST, many cases were missed, meaning sensitivity was actually low, not high.",
      "correct_choice_id": 220860,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25701501699350124/25701501699350124.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25701501699350124/25701501699350124.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90255,
      "choices": [
        {
          "id": 220863,
          "text": "It is used to determine cut off value"
        },
        {
          "id": 220864,
          "text": "On x axis 1-sensitivity"
        },
        {
          "id": 220865,
          "text": "on y axis sensitivity"
        },
        {
          "id": 220866,
          "text": "Curve D here is the best curve"
        }
      ],
      "text": "Considering the following graph which is not true?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/78.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3910260",
      "question_audio": null,
      "question_video": null,
      "map_id": 34239352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (On x-axis 1 - Sensitivity) The given question refers to a Receiver Operating Characteristic (ROC) Curve, which is used to evaluate the performance of a diagnostic test. ROC curves help determine the optimal cut-off value for a test, balancing sensitivity and specificity. The x-axis of an ROC curve represents (1 - Specificity), not (1 - Sensitivity). The y-axis represents Sensitivity (True Positive Rate). Thus, option B is incorrect because the x-axis does not represent 1 - Sensitivity, but rather 1 - Specificity. Incorrect Options: Option A (It is used to determine cut-off value) ROC curves help determine the best cut-off point where the test maximizes sensitivity and specificity. The ideal cut-off is usually where the curve is closest to the top-left corner (maximum sensitivity and specificity). Option C (On y-axis Sensitivity) The y-axis of the ROC curve correctly represents Sensitivity (True Positive Rate). Sensitivity measures the ability of a test to correctly identify positive cases. Option D (Curve D here is the best curve) In an ROC curve, the best-performing test has a curve closest to the upper left corner, where sensitivity is high and false positives are low. If Curve D is the highest and farthest from the diagonal reference line (random chance), it indicates the best test.",
      "correct_choice_id": 220864,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68734321699350140/68734321699350140.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68734321699350140/68734321699350140.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90256,
      "choices": [
        {
          "id": 220867,
          "text": "Lead-time bias"
        },
        {
          "id": 220868,
          "text": "Length bias"
        },
        {
          "id": 220869,
          "text": "Selection bias"
        },
        {
          "id": 220870,
          "text": "Surveillance bias"
        }
      ],
      "text": "If rapidly progressive cancers are missed by a screening test, which type of bias will occur?",
      "unique_key": "Q1788293",
      "question_audio": null,
      "question_video": null,
      "map_id": 34780135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Length Bias) Length bias occurs when slower-growing, less aggressive diseases are more likely to be detected by a screening test, while rapidly progressive diseases are missed because they progress too quickly between screening intervals. This is particularly important in cancer screening, where: Indolent (slow-growing) tumors are detected more frequently by screening. Aggressive (rapidly progressive) tumors develop and spread between screening intervals and are thus less likely to be detected early. As a result, screening programs may overestimate survival benefits by selectively detecting less fatal cases. Example in Cancer Screening: In breast cancer screening, slow-growing tumors are detected more often than aggressive ones, leading to an apparent increase in survival rates, even though actual outcomes may not improve significantly. In prostate cancer screening (PSA test), many low-grade prostate cancers are detected that might never cause symptoms, leading to overdiagnosis and overtreatment. Incorrect Options: A. Lead-Time Bias Lead-time bias occurs when early detection by screening makes survival appear longer without actually changing the course of the disease. Example: A lung cancer patient diagnosed via low-dose CT scan at Stage 1 vs. diagnosed at Stage 3 due to symptoms—if both die at the same time, survival seems longer in the first case, but actual life expectancy remains unchanged. Key difference: Lead-time bias affects survival time calculation, whereas length bias affects the type of cancers detected. C. Selection Bias Selection bias occurs when the study population is not representative of the general population. In screening studies, people who volunteer for screening may be healthier or more health-conscious than those who don’t, leading to overestimation of the benefits of screening. Key difference: Selection bias is related to who gets screened, while length bias is about the type of cancer detected. D. Surveillance Bias Surveillance bias (Detection bias) happens when a population under increased medical surveillance is more likely to be diagnosed with a disease than an unscreened population, even if there is no real difference in disease occurrence. Example: Women with frequent health check-ups are more likely to be diagnosed with thyroid nodules than those who don’t undergo routine exams, even though the actual incidence of thyroid disease is the same.",
      "correct_choice_id": 220868,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22084211699350744/22084211699350744.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22084211699350744/22084211699350744.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90257,
      "choices": [
        {
          "id": 220871,
          "text": "The relative risk (RR)"
        },
        {
          "id": 220872,
          "text": "The attributable risk reduction (ARR)"
        },
        {
          "id": 220873,
          "text": "The odd ratio (OR)"
        },
        {
          "id": 220874,
          "text": "The relative risk reduction (RRR)"
        }
      ],
      "text": "A cancer research institution has conducted a research to study the mortality benefits of an intervention. The results of two intervention studies are given below. What is the most useful measure of association in assessing the clinical relevance of these two studies?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/20(157).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4355169",
      "question_audio": null,
      "question_video": null,
      "map_id": 34584055,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (Attributable Risk Reduction - ARR) Attributable Risk Reduction (ARR) is the most useful measure of association in assessing the clinical relevance of these two studies. ARR is calculated as the absolute difference in event rates between the control group and the intervention group: ARR=Incidence in Control Group?Incidence in Intervention Group For Study A: ARR=1.3%?0.6%=0.7% For Study B: ARR=20%?9.2%=10.8% ARR directly quantifies the absolute benefit of an intervention, which is crucial in clinical decision-making because it allows physicians to estimate the real impact on patient outcomes, rather than a relative change. A higher ARR indicates a greater absolute reduction in mortality, making it an essential measure for evaluating the effectiveness of interventions across different studies. Incorrect Options: A. Relative Risk (RR) Relative Risk (RR) measures the ratio of event probabilities between intervention and control groups: RR= Incidence in Intervention Group/Incidence in Control group For Study A: RR=0.6%/1.3% = 0.46 For Study B: RR=9.2%/20% = 0.46 While RR shows how much an intervention reduces the relative risk of mortality, it does not provide an absolute measure of benefit. In studies where baseline risk differs significantly (as in Study A vs. Study B), RR alone may misrepresent the true impact, as a large RR reduction in a low-risk population may not translate to meaningful absolute risk reduction. C. Odds Ratio (OR) Odds Ratio (OR) compares the odds of an event occurring in one group to the odds in another group: OR= Odds in Intervention Group/Odd in control group OR is primarily used in case-control studies rather than intervention trials. It does not accurately estimate risk when event rates are high, making it less appropriate for clinical trials measuring mortality benefits. D. Relative Risk Reduction (RRR) RRR= ARR/Incidence in control group x 100 For Study A: RRR=0.7%/1.3% x 100 = 53.8% For Study B: RRR = 10.8%/20% x100 = 54% While RRR highlights the proportional reduction in risk, it does not account for the baseline risk and can exaggerate benefits if the initial risk is very low. This makes ARR a more clinically meaningful measure, as it quantifies the actual difference in patient outcomes.",
      "correct_choice_id": 220872,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}